Evaluation of the Endosafe® Portable Testing System™ for the Rapid Analysis of Biopharmaceutical Samples

References

1. 1.↵
   1. Jimenez L.

   1. Williams K.

   Endotoxin: Relevance and Control in Parenteral Manufacturing. In Microbial Contamination Control in the Pharmaceutical Industry; Jimenez L., Ed.; Marcel Dekker, Publishers: New York, 2004; pp 183–249.
2. 2.↵
   1. Anderson R. L.,
   2. Bland L. A.,
   3. Favero M. S.,
   4. McNeil M. M.,
   5. Davis B. J.,
   6. Mackel D. C.,
   7. Gravelle C. R.

   Factors associated with Pseudomonas pickettii intrinsic contamination of commercial respiratory therapy solutions marketed as sterile. Appl. Environ. Microbiol. 1985, 50 (6), 1343–1348.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Jimenez L.

   Microbial diversity in pharmaceutical product recalls and environments. PDA J. Pharm. Sci. Technol. 2007, 61 (5), 383–399.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   United States Pharmacopeia. Bacterial endotoxin test. In United States Pharmacopeia; Mack Publishing Company: Easton, Pennsylvania, 2006; pp 29, 2521–2524.
5. 5.↵
   1. Cooper J. F.,
   2. Hochstein D. H.,
   3. Seligman E. B.

   The Limulus test for endotoxin (Pyrogen) in radiopharmaceuticals and biologicals. Bull. Parenter. Drug Assoc. 1972, 26 (4), 153–162.

   OpenUrlPubMed
6. 6.↵
   1. Cohen J.,
   2. McConnell J. S.

   Observations on the measurement and evaluation of endotoxemia by a quantitative limulus lysate microassay. J. Infect. Dis. 1984, 150 (6), 916–924.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Nachum R.,
   2. Berzofsky R.

   Chromogenic Limulus amoebocyte lysate assay for rapid detection of gram-negative bacteriuria. J. Clin. Microbiol. 1985, 21 (5), 759–763.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. McCullough K. Z.,
   2. Weidner-Loeven C.

   Variability in the LAL test: comparison of three kinetic methods for the testing of pharmaceutical products. J. Parenter. Sci. Technol. 1992, 46 (3), 69–72.

   OpenUrlPubMed
9. 9.↵
   1. Scott B.,
   2. Wilcock A.

   Process analytical technology in the pharmaceutical industry: a toolkit for continuous improvement. PDA J. Pharm. Sci. Technol. 2006, 60 (1), 17–53.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Sutton S.

    Is real-time release through PAT compatible with the ideal of “science-based regulation”? Pharm. Technol. 2007, 31 (2), 97–98.

    OpenUrl
11. 11.↵
    1. English D.,
    2. Scalici C.,
    3. Hamilton J.,
    4. Jimenez L.

    Evaluation of the TECRATM visual immunoassay for detecting Staphylococcus aureus in cosmetic/pharmaceutical raw materials and finished products. J. Rapid Met. Autom. Microbiol. 1999, 7 (3), 193–203.

    OpenUrl
12. 12.↵
    1. Guschin D. Y.,
    2. Mobarry B. K.,
    3. Proudnikov D.,
    4. Stahl D. A.,
    5. Rittman B. E.,
    6. Mirzabekov A. D.

    Oligonucleotide microchips as genosensors for determinative and environmental studies in microbiology. Appl. Environ. Microbiol. 1997, 63 (6), 2397–2402.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Streefland M.,
    2. van de Waterbeemd B.,
    3. Happe H.,
    4. van der Pol L. A.,
    5. Beuvery E. C.,
    6. Tramper J.,
    7. Martens D. E.

    PAT for vaccines: the first stage of PAT implementation for development of a well-defined whole-cell vaccine against whooping cough disease. Vaccine 2007, 25 (16), 2994–3000.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Kawai M.,
    2. Matsutera E.,
    3. Kanda H.,
    4. Yamaguchi N.,
    5. Tani K.,
    6. Nasu M.

    16S ribosomal DNA-based analysis of bacterial diversity in purified water used in pharmaceutical manufacturing processes by PCR and denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. 2002, 68 (2), 699–704.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Venkateswaran K.,
    2. Hattori N.,
    3. La Duc M. T.,
    4. Kern R.

    ATP as a biomarker of viable microorganisms in clean-room facilities. J. Microbiol. Methods 2003, 52 (3), 367–377.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Jimenez L.

    Adenosine triphosphate bioluminescence analysis for rapid screening of microbial contamination in non-sterile pharmaceutical samples. PDA J. Pharm. Sci. Technol. 2004, 58 (3), 159–168.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Jimenez L.,
    2. Smalls S.,
    3. Ignar R.

    Use of PCR analysis for detecting low levels of bacteria and mold contamination in pharmaceutical samples. J. Microbiol. Methods 2000, 41 (3), 259–265.

    OpenUrlPubMed
18. 18.↵
    1. Gee A. P.,
    2. Sumstad D.,
    3. Stanson J.,
    4. Watson P.,
    5. Proctor J.,
    6. Kadidlo D.,
    7. Koch E.,
    8. Sprague J.,
    9. Wood D.,
    10. Styers D.,
    11. McKenna D.,
    12. Gallelli J.,
    13. Griffin D.,
    14. Read E. J.,
    15. Parish B.,
    16. Lindblad R.

    A multicenter comparison study between the Endosafe® PTS™ rapid-release testing system and traditional methods for detecting endotoxin in cell-therapy products. Cytotherapy 2008, 10 (4), 427–435.

    OpenUrlCrossRefPubMedWeb of Science